FOR IMMEDIATE RELEASE: April 13, 2021
Contact: Prudence Robertson, firstname.lastname@example.org | 240-672-2828
Washington, D.C. – Today the U.S. Food & Drug Administration (FDA) announced they will not enforce longstanding safety precautions that require doctors to dispense abortion-inducing drugs at an in-person visit to prevent severe side-effects.
“Pro-abortion activists have exploited the COVID-19 pandemic from the beginning, working to eliminate safety precautions in order to expand the proliferation of dangerous chemical abortion drugs,” said SBA List President Marjorie Dannenfelser. “This decision prioritizes abortion industry profits over the health and safety of women and puts the abortion extremism of the Biden-Harris administration on full display.”
“This decision is pure politics. The Biden-Harris FDA is acting in the financial interest of the big abortion lobby,” Dannenfelser added. “This is flagrant and dangerous disregard for the health and safety of American women and girls.”
A recent study reviewing reported adverse events over a 20-year period found that women can experience severe side-effects after taking the chemical abortion pill, include heavy bleeding, intense pain, and even death.
So far in 2021, legislators in Montana, Texas, Oklahoma, Indiana, Arizona, Arkansas, and Ohio are acting on the will of the people to pass laws protecting women by restricting chemical abortion.
SBA List is a network of 900,000 pro-life Americans nationwide, dedicated to ending abortion by electing national leaders and advocating for laws that save lives, with a special calling to promote pro-life women leaders.